| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
vomeronasal 1 receptor 17 pseudogene | 0.529 | 0.923 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2001 | 2020 | |||||||||
|
G protein-coupled receptor 166 pseudogene | 0.531 | 0.923 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2001 | 2020 | |||||||||
|
suppression of tumorigenicity 2 | 0.576 | 0.692 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2009 | 2019 | |||||||||
|
cardiomyopathy, dilated 1B (autosomal dominant) | 0.722 | 0.500 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2018 | 2020 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1977 | 2001 | |||||||||
|
long intergenic non-protein coding RNA 1193 | 0.565 | 0.692 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2006 | 2012 | |||||||||
|
immunoglobulin heavy constant gamma 3 (G3m marker) | 0.513 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1993 | 2008 | |||||||||
|
microRNA 152 | 0.521 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2016 | |||||||||
|
microRNA 19a | 0.512 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2017 | |||||||||
|
neutrophil migration | 0.473 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2018 | |||||||||
|
microRNA 744 | 0.617 | 0.615 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1672 | 0.462 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | |||||||||
|
RTEL1-TNFRSF6B readthrough (NMD candidate) | 0.682 | 0.385 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2018 | 2019 | |||||||||
|
PGR antisense RNA 1 | 0.514 | 0.808 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2001 | 2019 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 2 | 4 | 2011 | 2017 | |||||||||
|
long intergenic non-protein coding RNA 1063 | 1.000 | 0.077 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | |||||||||
|
ICOS ligand | 0.769 | 0.423 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2017 | |||||||||
|
MAS related GPR family member X2 | 0.743 | 0.423 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | |||||||||
|
Allergic rhinitis | 0.839 | 0.154 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2020 | |||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2012 | 2019 | |||||||||
|
immunoglobulin E concentration, serum | 1.000 | 0.077 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2003 | |||||||||
|
immunoglobulin heavy constant gamma 1 (G1m marker) | 0.700 | 0.500 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2008 | |||||||||
|
immunoglobulin heavy constant gamma 2 (G2m marker) | 0.760 | 0.192 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2008 | |||||||||
|
microRNA 142 | 0.480 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 | |||||||||
|
microRNA 192 | 0.503 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2018 |